Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
7 studies found for:    GDF3
Show Display Options
Rank Status Study
1 Completed Liothyronine and Heart Failure. The Long Term Effect of Liothyronine on Left Ventricular Ejection Fraction (LVEF)
Conditions: Heart Failure;   Low T3 Syndrome
Intervention: Drug: Liothyronine
2 Completed
Has Results
Effects of St. John's Wort on the Oral Contraceptive Hormone Levonorgestrel
Condition: Contraception
Interventions: Dietary Supplement: Placebo Control (Placebo Herb);   Dietary Supplement: St. John's Wort;   Drug: Levonorgestrel
3 Completed A Study of RO4905417 in Patients With Non ST-Elevation Myocardial Infarction (Non-STEMI) Undergoing Percutaneous Coronary Intervention
Condition: Myocardial Infarction
Interventions: Procedure: Percutaneous Coronary Intervention (PCI);   Drug: placebo;   Drug: RO4905417
4 Completed A Phase 1 Study To Evaluate The Safety And Tolerability Of PF-06252616 In Healthy Subjects
Condition: Healthy
Interventions: Biological: PF-06252616;   Drug: Placebo;   Biological: PF-06252161
5 Recruiting Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Conditions: Recurrent Adult Hodgkin Lymphoma;   Recurrent Adult T-cell Leukemia/Lymphoma;   Recurrent/Refractory Childhood Hodgkin Lymphoma;   Stage I Adult Hodgkin Lymphoma;   Stage I Adult T-cell Leukemia/Lymphoma;   Stage I Childhood Hodgkin Lymphoma;   Stage II Adult Hodgkin Lymphoma;   Stage II Adult T-cell Leukemia/Lymphoma;   Stage II Childhood Hodgkin Lymphoma;   Stage III Adult Hodgkin Lymphoma;   Stage III Adult T-cell Leukemia/Lymphoma;   Stage III Childhood Hodgkin Lymphoma;   Stage IV Adult Hodgkin Lymphoma;   Stage IV Adult T-cell Leukemia/Lymphoma;   Stage IV Childhood Hodgkin Lymphoma
Interventions: Other: Anthropometry;   Other: Serum Biomarkers;   Other: Diagnostic/symptom checklist;   Procedure: Echocardiogram;   Other: 6 minute walk test (6MWT);   Behavioral: Participant Questionnaires (ages >14 years only)
6 Completed Effect of Beverages Containing Different Doses of Alginate Fibers on Appetite, Energy Intake and Glycemia
Condition: Obesity
Interventions: Dietary Supplement: Alginate dietary fiber;   Dietary Supplement: Placebo
7 Completed Survival of Patients With Primary Prophylactic ICD Indication
Conditions: Primary Prevention;   Tachycardia, Ventricular;   Sudden Cardiac Death
Interventions: Other: Intensified diagnostic and treatment measures following 1st appropriate ICD therapy;   Other: Standard follow-up

Indicates status has not been verified in more than two years